TABLE 1.
DHA | Placebo | P-value | |
At randomization | |||
Age, y | 26.4 ± 5.1 | 25.8 ± 4.8 | 0.42 |
Gestational age, wk | 20.7 ± 2.0 | 20.6 ± 1.9 | 0.74 |
Primigravid, % | 32.2 | 36.8 | 0.52 |
Parity | 2.1 ± 1.0 | 2.0 ± 1.1 | 0.57 |
Weight, kg | 61.1 ± 9.9 | 62.0 ± 10.0 | 0.56 |
Height, cm | 154.4 ± 5.9 | 155.6 ± 5.4 | 0.16 |
BMI, 2 | 25.6 ± 3.6 | 25.6 ± 3.7 | 0.95 |
Schooling, y | 11.4 ± 3.6 | 11.7 ± 3.4 | 0.66 |
SES2 | −0.13 ± 1.0 | −0.08 ± 1.0 | 0.76 |
At delivery | |||
Gestational age, wk | 39.1 ± 2.0 | 39.4 ± 1.8 | 0.34 |
Premature, <37 wk, % | 8.1 | 7.0 | 0.79 |
Birth weight, g | 3245.6 ± 445.5 | 3254.1 ± 455.4 | 0.90 |
Values are means ± SD or percentages, = 87 for each group.
Using principal components analysis.